The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment - Poll - MDSpire

The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment

  • By

  • Aliki Vasilakou

  • Séverine Loizon

  • Maxime Dubois

  • Paôline Laurent

  • Vanja Sisirak

  • Dorothée Duluc

  • July 2, 2026

  • 0 min

Share

Original Source(s)

The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment

  • by Aliki Vasilakou, Séverine Loizon, Maxime Dubois, Paôline Laurent, Vanja Sisirak, Dorothée Duluc

  • July 2, 2026

Related Content

Targeting the E2F6-TOP2A-DKK1 axis: a novel therapeutic strategy for EMT-driven hepatocellular carcinoma progression

Editorial: National Colorectal Cancer Awareness Month 2025: Current Progress and Future Prospects on Colorectal Cancer Prevention, Diagnosis and Treatment

Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome